Mexican lab group Grupo Diagnóstico ProA is for sale, although management wants to keep a majority stake says Chief Innovation Officer, Carlos Perez Chavez. We talk to him about opportunities and look at Salud Digna.
The CEO of the Netherlands’ largest ambulatory clinic has quickly scotched rumours of a sale, as he tells Healthcare Europa the group is looking to expand at home and abroad, move into a new field, and is planning a possible IPO.
Healthcare Nova speaks to Hari Buggana, chairman and managing director at India-focused investor InvAscent, about what makes a good investment, and why the Indian healthcare market is appealing at the moment.
Colombia-based investment fund Tribeca Asset Management has launched a low-cost health care service in the Democratic Republic of the Congo. Fund founder Luc Gerard tells Healthcare Nova why Africa was the right target for an investor from LATAM looking to export its low-cost model.
The clock is ticking for businesses to comply with the General Data Protection Regulation, which comes into force on May 25. Healthcare Europa talks to Aetna International's CIO Alan Payne to find out what the data handling regulations mean for healthcare insurers and operators, and the challenges on the path to compliance.
We've been keeping our eye on German ophthalmology chain Ober Scharrer for months, and at long last we hear a sale looks imminent. Healthcare Europa speaks to a source in Germany about who is still in the running, and whether the prospective price could be putting buyers off.
A strong Q4 wasn’t enough to save pan-European private healthcare operator Capio from an almost 9% drop in profit for FY2017. Soon-to-depart CEO Thomas Berglund says the group is in a good position, with plans to restructure this year, and a greater focus on digital. But is this enough?
The outpatient sector in Europe, long fragmented into millions of providers, is the new frontier for consolidation. And no market is bigger than Germany where medical offices accounted for €51.5bn of expenditure in 2016 and statutory insurers spent €13.7bn alone on dentistry. Many investors and entrepreneurs have the sector in their sights.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
